Saturday, December 10, 2016

Cancer Research: An old avenue to reexplore

Science, too, should allow for the possibility that some avenues may have been untaken, due to the limitations of the time. Such is the case with cancer research:

"Cancer researchers and drug companies may have been too quick to ignore a promising line of inquiry that targets a specific cell protein, according to a research team."

https://www.sciencedaily.com/releases/2016/12/161209184821.htm